Consolidated Statement of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net loss	$ (7,931,427)	$ (12,024,759)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,451,665	5,064,860
Stock-based wages and salaries	589,216
Depreciation	1,040,915	1,061,549
Amortization of intangible assets	9,000	23,906
Amortization of original-issue-discounts	522,274	324,987
Bad debt expense	38,631	316,136
Impairment of intangible assets		252,462
Loss on sale of property and equipment		309,000
Cancellation of debt	(110,000)
Change in fair value of warrant liability	(180,468)	(218,039)
Stock-based interest expense	296,633	73,078
Stock-based consulting expense	917,694	3,386,044
Changes in operating assets and liabilities:
Accounts receivable	(64,960)	(3,706,157)
Inventory	1,239,847	294,424
Prepaid expenses	(8,115)	(14,210)
Operating lease right-of-use asset	140	(26,536)
Accounts payable and accrued expenses	733,022	1,462,301
Net cash used in operating activities	(1,455,933)	(3,420,954)
Investing activities:
Purchase of property and equipment	(15,000)
Deposits paid	(70,000)
Net cash used in investing activities	(85,000)
Financing activities:
Net proceeds received from notes and loans payable	2,255,000	2,854,853
Proceeds from sale of common stock		500,000
Repayments of notes and loans payable	(630,943)	(347,693)
Deferred financing costs	(178,000)	(77,706)
Amounts received from/repaid to related parties, net	53,000	76,970
Net cash provided by financing activities	1,499,057	3,006,424
Decrease in cash and cash equivalents	(41,876)	(414,530)
Cash and cash equivalents, beginning of period	73,194	449,001
Cash and cash equivalents, end of period	31,318	34,471
Supplemental Cash Flow Information:
Income taxes paid
Interest paid		72,346
Non-cash Investing and Financing Activities:
Issuance of common stock in lieu of repayment of notes payable	1,029,942
Issuance of common stock in asset acquisitions		1,767,498
Issuance of common stock for property and equipment	46,875
Debt discount associated with warrant liability	273,529	357,049
Conversion of Series A Preferred stock to common stock
Issuance of common stock resulting from exercise of warrants		8,641
Issuance of common stock warrants in connection with convertible promissory note	$ 937,787